Eltrombopag for Moderate Aplastic Anemia

NCT01328587 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NIH

Sponsor class

Conditions

Moderate Aplastic Anemia
Unilineage Bone Marrow Failure Disorders

Interventions

DRUG: Eltrombopag

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)